Inventor · disambiguated record
Shaojing Hu
Also filed as: HU SHAOJING
20 granted patents·13 pending applications·94 citations·filing 2004–2024
92Inventor score
Files withBETTA PHARMACEUTICALS CO LTD9INST PHARMACEUTICAL DISCOVERY7JACOBIO PHARMACEUTICALS CO LTD5INST FOR PHARM DISCOVERY INC4HU SHAOJING2
Top patents by PatentIndex Score
33 records- 0193US10988466B2Heterocyclic derivatives useful as SHP2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2018·Granted Apr 27, 2021·37 cites·2 claims
- 0291US11466005B2Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 11, 2022·2 cites·8 claims
- 0390US7465825B2Phenyl substituted carboxylic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2005·Granted Dec 16, 2008·18 cites·8 claims
- 0481US7498356B2Substituted amino carboxylic acidsINST FOR PHARM DISCOVERY INC·Filed 2005·Granted Mar 3, 2009·6 cites·11 claims
- 0580US8951959B2Glucagon-like peptide-1 analogues and uses thereofWANG YINXIANG·Filed 2011·Granted Feb 10, 2015·8 cites·6 claims
- 0674US7358248B2Substituted amino carboxylic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2004·Granted Apr 15, 2008·10 cites·34 claims
- 0774US2025011327A1Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0873US9242991B2Substituted fused heterocycles as c-Met tyrosine kinase inhibitorsHU SHAOJING·Filed 2011·Granted Jan 26, 2016·4 cites·43 claims
- 0972US2025223285A1Novel heterocyclic derivatives useful as shp2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1071US10059688B2Protein tyrosine kinase modulators and methods of useBETTA PHARMACEUTICALS CO LTD·Filed 2017·Granted Aug 28, 2018·1 cites·19 claims
- 1165US7358364B2Substituted carboxylic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2004·Granted Apr 15, 2008·2 cites·11 claims
- 1265US7329680B2Heterocycle substituted carboxylic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2004·Granted Feb 12, 2008·2 cites·29 claims
- 1364US9487570B2Glucagon like peptide analogs, composition, and method of useHU SHAOJING·Filed 2010·Granted Nov 8, 2016·1 cites·6 claims
- 1461US12103929B2Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 1, 2024·0 cites·20 claims
- 1561US7524878B2Phenyl substituted carboxylic acidsINST PHARMACEUTICALS DISCOVERY·Filed 2004·Granted Apr 28, 2009·3 cites·50 claims
- 1660US2016235757A1Icotinib-containing topical skin pharmaceutical compositions and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2014·Application pending·0 cites
- 1758US2019321369A1Icotinib-containing topical skin pharmaceutical compositions and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 1856US2008146574A1Heterocycle Substituted Carboxylic AcidsINST PHARMACEUTICAL DISCOVERY·Filed 2008·Application pending·0 cites
- 1955US9783524B2Protein tyrosine kinase modulators and methods of useBETTA PHARMACEUTICALS CO LTD·Filed 2014·Granted Oct 10, 2017·0 cites·9 claims
- 2055US2009082392A1Substituted Carboxylic AcidsINST FOR PHARM DISCOVERY INC·Filed 2008·Application pending·0 cites
- 2154US9688687B2Polymorphic forms of icotinib phosphate and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2014·Granted Jun 27, 2017·0 cites·25 claims
- 2253US9611272B2Polymorphic forms of icotinib and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2014·Granted Apr 4, 2017·0 cites·20 claims
- 2353US9085588B2Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereofBETTA PHARMACEUTICALS CO LTD·Filed 2012·Granted Jul 21, 2015·0 cites·32 claims
- 2450US2024383905A1Fgfr inhibitors and methods of use thereof3H PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2547US9505774B2Polymorphic forms of icotinib maleate and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2014·Granted Nov 29, 2016·0 cites·24 claims
- 2646US2004248937A1Substituted phenylalkanoic acids for the treatment of diabetesINST PHARMACEUTICAL DISCOVERY·Filed 2004·Application pending·0 cites
- 2743US2005009817A1Substituted heteroarylsFiled 2004·Application pending·0 cites
- 2843US2007078135A1Substituted heteroaryl CB1 antagonistsNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 2941US10577364B2Crystalline form of fused pyridine derivative's maleate and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2016·Granted Mar 3, 2020·0 cites·20 claims
- 3041US2006122222A1Heterocycle substituted carboxylic acidsINST FOR PHARM DISCOVERY INC·Filed 2005·Application pending·0 cites
- 3141US2006100251A1Substituted phenylalkanoic acidsINST FOR PHARM DISCOVERY INC·Filed 2005·Application pending·0 cites
- 3240US2006094747A1Substituted carboxylic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2005·Application pending·0 cites
- 3334US9617257B2Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitorsBETA PHARMACEUTICALS CO LTD·Filed 2013·Granted Apr 11, 2017·0 cites·38 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →